Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Epithelial MMP-2 expression correlates with worse prognosis in pancreatic cancer.

Juuti A, Lundin J, Nordling S, Louhimo J, Haglund C.

Oncology. 2006;71(1-2):61-8. Epub 2007 Mar 21.

PMID:
17377415
2.

The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters.

Giannopoulos G, Pavlakis K, Parasi A, Kavatzas N, Tiniakos D, Karakosta A, Tzanakis N, Peros G.

Anticancer Res. 2008 May-Jun;28(3B):1875-81.

4.

Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression.

Torng PL, Mao TL, Chan WY, Huang SC, Lin CT.

Gynecol Oncol. 2004 Feb;92(2):559-67.

PMID:
14766248
5.

RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.

Masui T, Doi R, Koshiba T, Fujimoto K, Tsuji S, Nakajima S, Koizumi M, Toyoda E, Tulachan S, Ito D, Kami K, Mori T, Wada M, Noda M, Imamura M.

Clin Cancer Res. 2003 May;9(5):1779-84.

6.

Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.

Unsal D, Akyurek N, Uner A, Erpolat OP, Han U, Akmansu M, Mentes BB, Dursun A.

Am J Clin Oncol. 2008 Feb;31(1):55-63. doi: 10.1097/COC.0b013e318068b4e2.

PMID:
18376229
7.

Prognostic impact of cysteine proteases cathepsin B and cathepsin L in pancreatic adenocarcinoma.

Niedergethmann M, Wostbrock B, Sturm JW, Willeke F, Post S, Hildenbrand R.

Pancreas. 2004 Oct;29(3):204-11.

PMID:
15367886
8.
9.

Increased expression of matrix metalloproteinases-21 and -26 and TIMP-4 in pancreatic adenocarcinoma.

Bister V, Skoog T, Virolainen S, Kiviluoto T, Puolakkainen P, Saarialho-Kere U.

Mod Pathol. 2007 Nov;20(11):1128-40. Epub 2007 Sep 14.

10.

Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.

Juuti A, Louhimo J, Nordling S, Ristimäki A, Haglund C.

J Clin Pathol. 2006 Apr;59(4):382-6. Epub 2006 Feb 7.

11.

CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer.

Ikenaga N, Ohuchida K, Mizumoto K, Cui L, Kayashima T, Morimatsu K, Moriyama T, Nakata K, Fujita H, Tanaka M.

Gastroenterology. 2010 Sep;139(3):1041-51, 1051.e1-8. doi: 10.1053/j.gastro.2010.05.084. Epub 2010 Jun 8.

PMID:
20685603
12.
13.

Expression of the MMP-1 in human pancreatic carcinoma: relationship with prognostic factor.

Ito T, Ito M, Shiozawa J, Naito S, Kanematsu T, Sekine I.

Mod Pathol. 1999 Jul;12(7):669-74.

PMID:
10430270
14.

Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9.

Sienel W, Polzer B, Elshawi K, Lindner M, Morresi-Hauf A, Vay C, Eder F, Passlick B, Klein CA.

Mod Pathol. 2008 Sep;21(9):1130-8. doi: 10.1038/modpathol.2008.102. Epub 2008 Jun 20.

15.

Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.

Nitori N, Ino Y, Nakanishi Y, Yamada T, Honda K, Yanagihara K, Kosuge T, Kanai Y, Kitajima M, Hirohashi S.

Clin Cancer Res. 2005 Apr 1;11(7):2531-9.

16.

Expression of matrix metalloproteinases 7 and 2 in human renal cell carcinoma.

Sumi T, Nakatani T, Yoshida H, Hyun Y, Yasui T, Matsumoto Y, Nakagawa E, Sugimura K, Kawashima H, Ishiko O.

Oncol Rep. 2003 May-Jun;10(3):567-70.

PMID:
12684625
19.

Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters.

Merati K, said Siadaty M, Andea A, Sarkar F, Ben-Josef E, Mohammad R, Philip P, Shields AF, Vaitkevicius V, Grignon DJ, Adsay NV.

Am J Clin Oncol. 2001 Oct;24(5):447-52.

PMID:
11586094
20.

Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer.

Djonov V, Cresto N, Aebersold DM, Burri PH, Altermatt HJ, Hristic M, Berclaz G, Ziemiecki A, Andres AC.

Int J Oncol. 2002 Jul;21(1):25-30.

PMID:
12063545

Supplemental Content

Support Center